Bioral Amphotericin B: IND submitted

By WIR Staff | Feb 12, 2007 | 8:00 AM GMT

BDSI submitted an IND for an open-label, U.S. Phase I

Read the full 107 word article

How to gain access

Continue reading with a
two-week free trial.